Abstract
Human papillomavirus (HPV ) has been extensively associated with the development of cervical cancer due to the expression of oncoproteins like E7. This protein can interfere with pRB tumor suppressor activity, enabling the uncontrolled proliferation of abnormal cells. DNA vaccines are known as the third-generation vaccines, providing the ability of targeting viral infections such as HPV in a preventive and therapeutic way. Although current strategies make use of plasmid DNA (pDNA) as the vector of choice to be used as a DNA vaccine, minicircle DNA (mcDNA) has been proving its added value as a non-viral DNA vector by demonstrating higher expression efficiency and increased biosafety than the pDNA. However, due to its innovative profile, few methodologies have been explored and implemented for the manufacture of this molecule. This chapter describes the detailed procedures for the production, extraction, and purification of supercoiled E7-mcDNA vaccine, by using size-exclusion chromatography to obtain mcDNA with a purity degree which meets the regulatory agency criteria. Then, the assessment of E7 antigen expression through immunocytochemistry is also described.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vande Pol SB, Klingelhutz AJ (2013) Papillomavirus E6 oncoproteins. Virology 445:115–137
Roman A, Munger K (2013) The papillomavirus E7 proteins. Virology 445:138–168
Almeida AM, Queiroz JA, Sousa F et al (2019) Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins. Drug Discov Today 24:2044–2057
Peng S, Tomson TT, Trimble C et al (2006) A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effects. Gene Ther 13:257–265
Gaspar V, de Melo-Diogo D, Costa E et al (2015) Minicircle DNA vectors for gene therapy: advances and applications. Expert Opin Biol Ther 15:353–379
Mayrhofer P, Schleef M, Jechlinger W (2009) Use of minicircle plasmids for gene therapy. Methods Mol Biol 542:87–104
Dietz WM, Skinner NEB, Hamilton SE et al (2013) Minicircle DNA is superior to plasmid DNA in eliciting antigen-specific CD8+ T-cell responses. Mol Ther 21:1526–1535
Gaspar VM, Maia CJ, Queiroz JA et al (2014) Improved minicircle DNA biosynthesis for gene therapy applications. Hum Gene Ther Methods 25:93–105
Chen Z-Y, He C-Y, Kay MA (2005) Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. Hum Gene Ther 16:126–131
(2008) Guidance for Industry: Considerations for plasmid DNA vaccines for infectious disease indications. Biotechnol Law Rep 26:641–647
Mayrhofer P, Blaesen M, Schleef M et al (2008) Minicircle-DNA production by site specific recombination and protein-DNA interaction chromatography. J Gene Med 10:1253–1269
Hou XH, Guo XY, Chen Y et al (2015) Increasing the minicircle DNA purity using an enhanced triplex DNA technology to eliminate DNA contaminants. Mol Ther Methods Clin Dev 1:14062
Alves CPA, Šimčíková M, Brito L et al (2016) Development of a nicking endonuclease-assisted method for the purification of minicircles. J Chromatogr A 1443:136–144
Almeida AM, Queiroz JA, Sousa F et al (2019) Minicircle DNA purification: performance of chromatographic monoliths bearing lysine and cadaverine ligands. J Chromatogr B Anal Technol Biomed Life Sci 1118–1119:7–16
Silva-Santos AR, Alves CPA, Monteiro G et al (2019) Multimodal chromatography of supercoiled minicircles: a closer look into DNA-ligand interactions. Sep Purif Technol 212:161–170
Almeida AM, Černigoj U, Queiroz JA et al (2020) Quality assessment of supercoiled minicircle DNA by cadaverine-modified analytical chromatographic monolith. J Pharm Biomed Anal 180:113037
Almeida AM, Eusébio D, Queiroz JA et al (2020) The use of size-exclusion chromatography in the isolation of supercoiled minicircle DNA from Escherichia coli lysate. J Chromatogr A 1609:460444
Almeida AM, Tomás J, Pereira P et al (2018) HPV-16 targeted DNA vaccine expression: the role of purification. Biotechnol Prog 34:546–551
Grove A, Kushwaha AK, Nguyen KH (2015) Determining the role of metal binding in protein cage assembly. Methods Mol Biol 1252:91–100
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Almeida, A.M., Eusébio, D., Queiroz, J.A., Sousa, F., Sousa, Â. (2021). Minicircle DNA Vaccine Purification and E7 Antigen Expression Assessment. In: Sousa, Â. (eds) DNA Vaccines. Methods in Molecular Biology, vol 2197. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0872-2_11
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0872-2_11
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0871-5
Online ISBN: 978-1-0716-0872-2
eBook Packages: Springer Protocols